MetaADEDB 2.0 @ LMMD
Vincristine
(AQTQHPDCURKLKT-JKDPCDLQSA-N)
Structure
SMILES
OS(=O)(=O)O.O=CN1c2cc(OC)c(cc2[C@]23[C@@H]1[C@@](O)(C(=O)OC)[C@H](OC(=O)C)[C@]1([C@@H]3N(CC2)CC=C1)CC)[C@]1(C[C@@H]2CN(CCc3c1[nH]c1c3cccc1)C[C@](C2)(O)CC)C(=O)OC
Molecular Formula:
C46H58N4O14S
Molecular Weight:
923.036
Log P:
4.5222
Hydrogen Bond Acceptor:
17
Hydrogen Bond Donor:
5
TPSA:
254.15
CAS Number(s):
2068-78-2; 1217704-93-2
Synonym(s)
1.
Vincristine
2.
Leurocristine
3.
Citomid
4.
Farmistin
5.
Oncovin
6.
Oncovine
7.
Onkocristin
8.
Vincasar
9.
Vincasar PFS
10.
Vincristin Bristol
11.
Vincristin medac
12.
Vincristine Sulfate
13.
Vincrisul
14.
Vintec
15.
cellcristin
16.
PFS, Vincasar
17.
Sulfate, Vincristine
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Incorrect route of drug administrationFAERS: 9US FAERS
2Mononeuropathy MultiplexFAERS: 9US FAERS
3Respiratory FailureFAERS: 8US FAERS
4Autonomic neuropathyFAERS: 7US FAERS
5NeutropeniaFAERS: 6US FAERS
6AstheniaFAERS: 5US FAERS
7Vocal Cord ParalysisFAERS: 5
Canada Vigilance: 8
Canada Vigilance
US FAERS
8VomitingFAERS: 5US FAERS
9ConstipationFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
10Medication ErrorFAERS: 4US FAERS
11QuadriplegiaFAERS: 4US FAERS
12White blood cell count decreasedFAERS: 4US FAERS
13Abdominal PainFAERS: 3US FAERS
14HeadacheFAERS: 3US FAERS
15PneumoniaFAERS: 3US FAERS
16DysgeusiaFAERS: 2US FAERS
17DysphoniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
18Febrile NeutropeniaFAERS: 2US FAERS
19Gastrointestinal PainFAERS: 2US FAERS
20General physical health deteriorationFAERS: 2US FAERS
21HypotensionFAERS: 2US FAERS
22Ileal ulcerFAERS: 2US FAERS
23Incorrect dose administeredFAERS: 2US FAERS
24IntussusceptionFAERS: 2US FAERS
25Mental status changesFAERS: 2US FAERS
26NauseaFAERS: 2US FAERS
27Occult blood positiveFAERS: 2US FAERS
28PainFAERS: 2US FAERS
29ParaplegiaFAERS: 2US FAERS
30PolyneuropathyFAERS: 2US FAERS
31Product label confusionFAERS: 2US FAERS
32ShockFAERS: 2US FAERS
33Wrong drug administeredFAERS: 2US FAERS
34nervous system disorderFAERS: 2US FAERS
35AbasiaFAERS: 1US FAERS
36Abdominal massFAERS: 1US FAERS
37AbscessFAERS: 1US FAERS
38Accidental exposure to productFAERS: 1US FAERS
39Accidental exposureFAERS: 1US FAERS
40Accidental overdoseFAERS: 1US FAERS
41Acute Motor Axonal NeuropathyFAERS: 1US FAERS
42Acute respiratory failureFAERS: 1US FAERS
43AphasiaFAERS: 1US FAERS
44ArthralgiaFAERS: 1US FAERS
45AscitesFAERS: 1US FAERS
46Blood albumin decreasedFAERS: 1US FAERS
47Blood count abnormalFAERS: 1US FAERS
48Blood lactate dehydrogenase increasedFAERS: 1US FAERS
49Bone scan abnormalFAERS: 1US FAERS
50Brain DeathFAERS: 1US FAERS
51Candida test positiveFAERS: 1US FAERS
52Cardiac ArrestFAERS: 1US FAERS
53Chest PainFAERS: 1US FAERS
54ChylothoraxFAERS: 1US FAERS
55ColitisFAERS: 1US FAERS
56Cortical laminar necrosisFAERS: 1US FAERS
57Depressed Level of ConsciousnessFAERS: 1US FAERS
58Device occlusionFAERS: 1US FAERS
59Diabetes InsipidusFAERS: 1US FAERS
60DiplopiaFAERS: 1US FAERS
61Drug administered at inappropriate siteFAERS: 1US FAERS
62Drug administration errorFAERS: 1US FAERS
63Drug toxicityFAERS: 1US FAERS
64DysuriaFAERS: 1US FAERS
65ErythemaFAERS: 1US FAERS
66Escherichia infectionFAERS: 1US FAERS
67FatigueFAERS: 1US FAERS
68Febrile bone marrow aplasiaFAERS: 1US FAERS
69FlushingFAERS: 1US FAERS
70Guillain-Barre SyndromeFAERS: 1US FAERS
71Human metapneumovirus test positiveFAERS: 1US FAERS
72HypophagiaFAERS: 1US FAERS
73HypoxiaFAERS: 1US FAERS
74Iatrogenic injuryFAERS: 1US FAERS
75Impaired gastric emptyingFAERS: 1US FAERS
76InfluenzaFAERS: 1US FAERS
77Injury associated with deviceFAERS: 1US FAERS
78Intestinal ObstructionFAERS: 1US FAERS
79Intestinal PerforationFAERS: 1US FAERS
80Laryngeal nerve dysfunctionFAERS: 1US FAERS
81LymphangiomaFAERS: 1US FAERS
82Lymphocyte percentage decreasedFAERS: 1US FAERS
83LymphomaFAERS: 1US FAERS
84MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
85MalaiseFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
86Malignant ascitesFAERS: 1US FAERS
87Mastication disorderFAERS: 1US FAERS
88MegacolonFAERS: 1US FAERS
89MeningismFAERS: 1US FAERS
90Monocyte percentage decreasedFAERS: 1US FAERS
91Neutropenic colitisFAERS: 1US FAERS
92Neutrophil count decreasedFAERS: 1US FAERS
93Neutrophil percentage increasedFAERS: 1US FAERS
94Night sweatsFAERS: 1US FAERS
95NocturiaFAERS: 1US FAERS
96OliguriaFAERS: 1US FAERS
97OverdoseFAERS: 1US FAERS
98PancytopeniaFAERS: 1US FAERS
99ParaparesisFAERS: 1US FAERS
100PneumothoraxFAERS: 1US FAERS
101PoisoningFAERS: 1US FAERS
102Post procedural complicationFAERS: 1US FAERS
103Product label issueFAERS: 1US FAERS
104Product quality issueFAERS: 1US FAERS
105Protein total decreasedFAERS: 1US FAERS
106Pulmonary HypertensionFAERS: 1US FAERS
107RalesFAERS: 1US FAERS
108Respiratory arrestFAERS: 1US FAERS
109SepsisFAERS: 1US FAERS
110Septic ShockFAERS: 1US FAERS
111Sinus TachycardiaFAERS: 1US FAERS
112SubileusFAERS: 1US FAERS
113TachycardiaFAERS: 1US FAERS
114ThrombocytopeniaFAERS: 1US FAERS
115TracheobronchitisFAERS: 1US FAERS
116Transaminases increasedFAERS: 1US FAERS
117Troponin increasedFAERS: 1US FAERS
118Venoocclusive diseaseFAERS: 1US FAERS
119Visual ImpairmentFAERS: 1US FAERS
120Walking aid userFAERS: 1US FAERS
121Wrong technique in drug usage processFAERS: 1US FAERS
122AlopeciaCanada Vigilance: 2Canada Vigilance
123Ewing's sarcoma recurrentCanada Vigilance: 1Canada Vigilance
124Gastric DilatationCanada Vigilance: 1Canada Vigilance
125NeuralgiaCanada Vigilance: 1Canada Vigilance
126NeuritisCanada Vigilance: 1Canada Vigilance
127Oropharyngeal painCanada Vigilance: 2Canada Vigilance
128Product use in unapproved indicationCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.